Kasuga, Akiyoshi http://orcid.org/0000-0002-2234-1135
Hamamoto, Yasuo
Takeuchi, Ayano
Okano, Naohiro
Togasaki, Kazuhiro
Aoki, Yu
Suzuki, Takeshi
Kawasaki, Kenta
Hirata, Kenro
Sukawa, Yasutaka
Kanai, Takanori
Takaishi, Hiromasa
Article History
Received: 9 February 2018
Accepted: 14 March 2018
First Online: 23 March 2018
Compliance with ethical standards
:
: All authors declare no Conflicts of Interests for this article.Takanori Kanai received research grants from Astellas Pharm Inc., Astra-Zeneca K.K., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Eisai Pharmaceutical Co. Ltd., Zeria Pharmaceutical Co. Ltd., Tanabe Mitsubishi Pharmaceutical Co. Ltd., JIMRO Co. Ltd., Kyorin Pharmaceutical Co. Ltd., and received service honoraria from Astellas Pharm Inc., Eisai Pharmaceutical Co. Ltd., JIMRO Co. Ltd., Tanabe Mitsubishi Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Co. Ltd., Miyarisan Pharmaceutical Co. Ltd., and Zeria Pharmaceutical Co. Ltd. Hiromasa Takaishi received research grants from Taiho Pharmaceutical Co. Ltd., and Yakult Honsha Pharmaceutical Co. Ltd., outside the submitted work.
: This article does not contain any studies with human participants or animals performed by any of the authors.We did not use individual data but published data. These data have been widely utilized in research and are generally available. Therefore, we confirm that any aspect of the work covered in this manuscript has been conducted with ethical approval. And this study is registered in the PROSPERO database (CRD42017071274) and was conducted according to the Preferred Reporting Items for Systemic Reviews and Meta-Analysis (PRISMA) statement.